Ostro, a leading AI-powered engagement platform trusted by over half of the top 20 global pharmaceutical companies, has launched Ostro Airmark, a groundbreaking solution that transforms static brand emails into dynamic, compliant conversational AI for healthcare professionals (HCPs). This innovation enables real-time, interactive communication within the email channel, enhancing engagement and driving actionable outcomes.
Ostro Airmark embeds AI to turn static pharma emails into responsive, compliant conversations.
HCPs can interact directly in emails, receiving instant, PRC-approved responses.
Adaptive learning tailors messaging based on individual HCP interactions.
CRM integration with platforms like Veeva and Salesforce enhances targeting.
Real-time data capture closes the loop between engagement and commercial outcomes.
Airmark operates within Ostro’s omnichannel ecosystem for continuous optimization.
Traditional email strategies in the pharmaceutical industry often fail to engage HCPs effectively, requiring them to switch channels for actions or answers. Ostro Airmark addresses this by embedding AI-powered intelligence into emails, enabling HCPs to ask questions and receive compliant, real-time responses without leaving their inbox. This eliminates the need for portals or logins, streamlining communication and boosting engagement rates.
“Pharma emails aren’t falling short because of the content. They’re falling short because there’s no way to engage,” said Chase Feiger, MD, co-founder and CEO of Ostro. “Airmark makes it possible for HCPs to ask a question, get an approved response, and take the next step—all without leaving their email. That’s how you make the channel truly useful.”
Airmark’s capabilities transform email into a dynamic engagement tool. Its interactive messaging allows HCPs to request information directly within an email, receiving instant, compliant responses with full audit trails. The adaptive learning feature personalizes messaging based on HCP interactions, ensuring relevance over time. Additionally, Airmark integrates with CRM platforms like Veeva, Salesforce, and IQVIA, capturing every interaction to enable sharper targeting and faster insights.
“Email remains the backbone of HCP communications, but traditional approaches leave too much potential on the table,” said Donna Murphy, Global CEO at Havas Health & Creative Networks. “Airmark represents a paradigm shift, finally giving life sciences companies the ability to create genuine, two-way dialogue within the channel HCPs actually use daily.”
Airmark integrates seamlessly with Ostro’s omnichannel ecosystem, including Ostro Tailor, which delivers PRC-approved micro-content on HCP websites. This closed-loop system identifies HCP interests, re-engages through intelligent email follow-ups, and captures real-time feedback for continuous optimization. The result is a cohesive strategy that drives high-value actions and improves outcomes.
“Airmark continues to expand the Ostro platform by fostering deeper engagement with HCPs through innovative and dynamic approaches,” said Arpa Garay, CEO at Harp Healthcare Advisors, LLC and former Chief Marketing Officer at Merck & Chief Commercial Officer at Moderna. “The ability to deliver relevant, compliant information instantly within email means physicians can access relevant information faster, resulting in better patient care.”
Airmark ensures regulatory compliance while delivering personalized experiences HCPs expect. Its real-time data capture and CRM integration enable pharmaceutical companies to align email engagement with commercial outcomes, closing the feedback loop.
“What impressed us most about Airmark is how it maintains regulatory compliance while delivering the kind of personalized experience HCPs have come to expect in every other industry,” said Stacy Stone, Executive Director of Omnichannel at Pacira Biosciences. “The real-time data capture and CRM integration means we can finally close the loop between email engagement and commercial outcomes.”
Ostro will showcase Airmark at Fierce Pharma Week, September 8-11, 2025, with live demonstrations at Booth #719 and sessions on AI-powered omnichannel engagement.
The launch of Ostro Airmark marks a significant step toward modernizing HCP engagement, offering pharmaceutical companies a powerful tool to transform email into a dynamic, compliant, and impactful channel. By enabling real-time, personalized interactions, Airmark sets a new standard for digital engagement in life sciences.
Ostro is a leader in AI-powered digital engagement solutions, dedicated to helping life sciences brands create meaningful interactions that drive better outcomes. Through its innovative technology, Ostro enables organizations to connect with patients, caregivers, and healthcare providers in personalized, impactful, and compliant ways.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.